Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1105 | 991 | 1153 | 1255 | 1305 | 1816 |
Fund Return | 10.54% | -0.92% | 15.29% | 7.87% | 5.46% | 6.15% |
Place in category | 281 | 336 | 260 | 208 | 203 | 83 |
% in Category | 46 | 55 | 41 | 41 | 44 | 23 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Legal General US Index Trust C Dist | 901.34M | 27.74 | 12.07 | 15.27 | ||
Legal General US Index Trust I Acc | 1.78B | 27.75 | 12.04 | 15.23 | ||
Legal General US Index Trust I Dist | 1.8B | 27.69 | 12.02 | 15.22 | ||
Legal General US Index Trust C Acc | 3.76B | 27.84 | 12.09 | 15.28 | ||
Legal General US Index Trust F Acc | 587.92K | 26.93 | 10.90 | 14.79 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
All Share Index Unit Trust Income | 15.02B | 11.14 | 7.78 | 6.09 | ||
VG UK Plus GBP Accumulation | 15.02B | 11.14 | 7.80 | 6.12 | ||
VG UK Institutional Plus GBP Income | 15.02B | 11.15 | 7.79 | 6.11 | ||
Index Unit Trust Accumulation | 15.02B | 9.33 | 5.76 | 6.10 | ||
UK Equity Tracker Fund X Acc | 11.63B | 9.31 | 6.12 | 6.33 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Shell | GB00BP6MXD84 | 6.69 | 31.98 | -0.20% | |
AstraZeneca | GB0009895292 | 6.66 | 11,046.0 | +0.05% | |
HSBC | GB0005405286 | 5.53 | 829.30 | +0.77% | |
Unilever | GB00B10RZP78 | 4.84 | 54.46 | +0.70% | |
Relx | GB00B2B0DG97 | 2.79 | 3,980.00 | -0.30% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review